Inventor · disambiguated record
Giles Albert Brown
Also filed as: BROWN GILES · BROWN GILES A · BROWN GILES ALBERT
68 granted patents·21 pending applications·573 citations·filing 2004–2025
99Inventor score
Files withHEPTARES THERAPEUTICS LTD60NXERA PHARMA UK LTD13PROXIMAGEN LLC3ASTRAZENECA AB PUBL2BROWN GILES ALBERT2
Top patents by PatentIndex Score
89 records- 0198US11352342B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2020·Granted Jun 7, 2022·9 cites·10 claims
- 0298US11254656B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2020·Granted Feb 22, 2022·10 cites·10 claims
- 0398US11014880B2Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2020·Granted May 25, 2021·9 cites·13 claims
- 0498US10961225B2Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptorHEPTARES THERAPEUTICS LTD·Filed 2020·Granted Mar 30, 2021·11 cites·16 claims
- 0598US9670183B2Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2015·Granted Jun 6, 2017·34 cites·23 claims
- 0697US11834407B2Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2021·Granted Dec 5, 2023·5 cites·13 claims
- 0797US11773090B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2020·Granted Oct 3, 2023·6 cites·10 claims
- 0897US11319312B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2020·Granted May 3, 2022·10 cites·20 claims
- 0997US10973832B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Apr 13, 2021·10 cites·16 claims
- 1097US10689368B2Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptorHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Jun 23, 2020·12 cites·20 claims
- 1197US10329278B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Jun 25, 2019·13 cites·17 claims
- 1297US10196380B2Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Feb 5, 2019·20 cites·16 claims
- 1396US11091456B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Aug 17, 2021·10 cites·20 claims
- 1496US11034704B2Muscarinic receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Jun 15, 2021·10 cites·13 claims
- 1596US10759751B2Substituted spirocyclohexanes as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Sep 1, 2020·12 cites·18 claims
- 1696US10752610B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Aug 25, 2020·10 cites·20 claims
- 1796US10259787B2Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Apr 16, 2019·13 cites·8 claims
- 1896US9926297B2Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Mar 27, 2018·19 cites·18 claims
- 1996US9758506B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Sep 12, 2017·22 cites·20 claims
- 2095US10548884B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Feb 4, 2020·11 cites·17 claims
- 2195US10385039B2Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Aug 20, 2019·13 cites·20 claims
- 2295US9907805B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Mar 6, 2018·15 cites·10 claims
- 2394US12024499B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2022·Granted Jul 2, 2024·2 cites·7 claims
- 2494US10413553B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Sep 17, 2019·11 cites·8 claims
- 2594US10030035B2Muscarinic receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2015·Granted Jul 24, 2018·14 cites·17 claims
- 2694US9669013B2Bicyclic aza compounds as muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Jun 6, 2017·14 cites·18 claims
- 2794US9573929B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2015·Granted Feb 21, 2017·12 cites·4 claims
- 2894US9266857B2Bicyclic AZA compounds as muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2013·Granted Feb 23, 2016·23 cites·14 claims
- 2993US10738029B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Aug 11, 2020·12 cites·6 claims
- 3093US10428088B2Muscarinic receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Oct 1, 2019·11 cites·10 claims
- 3193US10351545B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Jul 16, 2019·10 cites·30 claims
- 3293US10167272B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Jan 1, 2019·11 cites·21 claims
- 3393US10112923B21,2,4-triazine-4-amine derivativesHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Oct 30, 2018·20 cites·3 claims
- 3493US9975890B2Bicyclic AZA compounds as muscarinic M1 receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted May 22, 2018·10 cites·9 claims
- 3593US9187451B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2012·Granted Nov 17, 2015·15 cites·14 claims
- 3692US10858352B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Dec 8, 2020·11 cites·20 claims
- 3792US10787447B2Pharmaceutical compoundsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Sep 29, 2020·11 cites·18 claims
- 3892US10259802B2Bicyclic aza compounds as muscarinic M1 receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Apr 16, 2019·9 cites·20 claims
- 3991US11324738B2Muscarinic agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted May 10, 2022·9 cites·18 claims
- 4091US11208396B2Oxime compounds as agonists of the muscarinic M1 and/or M4 receptorHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Dec 28, 2021·9 cites·16 claims
- 4191US10167284B2Spirocyclic compounds as agonists of the muscarinic M1 receptor and/or M4 receptorHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Jan 1, 2019·12 cites·20 claims
- 4291US9593106B2Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2014·Granted Mar 14, 2017·20 cites·12 claims
- 4389US10030012B2Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Jul 24, 2018·9 cites·2 claims
- 4488US10995091B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2018·Granted May 4, 2021·3 cites·14 claims
- 4587US11945801B2Bicyclic aza compounds as muscarinic M1 and/or M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Apr 2, 2024·3 cites·15 claims
- 4685US10155761B2CXCR4 receptor antagonistsPROXIMAGEN LLC·Filed 2017·Granted Dec 18, 2018·4 cites·16 claims
- 4783US9353086B2CXCR4 receptor antagonistsSAVORY EDWARD DANIEL·Filed 2011·Granted May 31, 2016·6 cites·17 claims
- 4882US8809525B21,2,4-triazine-4-amine derivativesCONGREVE MILES STUART·Filed 2011·Granted Aug 19, 2014·7 cites·11 claims
- 4979US10988455B21,2,4-triazine-4-amine derivativesHEPTARES THERAPEUTICS LTD·Filed 2018·Granted Apr 27, 2021·1 cites·23 claims
- 5078US11793817B2Muscarinic M1 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2021·Granted Oct 24, 2023·0 cites·12 claims
Showing the top 50 of 89 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Giles Albert Brown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →